The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
Open accessAbstract
Purpose: Primary systemic amyloidosis (AL) is a multisystemic disorder resulting from an underlying plasma cell dyscrasia. There is no formal staging system for AL, making comparisons between studies and treatment centers difficult. Our group previously identified elevated serum cardiac troponin T (cTnT) as the most powerful predictor of overall survival. Others have reported that N-terminal pro-brain natriuretic peptide (NT-proBNP) is a valuable prognostic marker. We sought to develop a staging system for patients with AL. Patients and Methods: Two hundred forty-two patients with newly diagnosed AL who were seen at the Mayo Clinic between April 1979 and November 2000, and who had echocardiograms and stored serum samples at presentation were eligible for this retrospective review. NT-proBNP measurements were performed on 242 patients in whom cTnT and cardiac troponin I (cTnI) had been previously run. Two prognostic models were designed using threshold values of NT-proBNP and either cTnT or cTnI (NT-proBNP < 332 ng/L, cTnT < 0.035 μg/L, and cTnI < 0.1 μg/L). Depending on whether NT-proBNP and troponin levels were both low, were high for only one level, or were both high, patients were classified as stage I, II, or III, respectively. Results: Using the cTnT+NT-proBNP model 33%, 30%, and 37% of patients were stages I, II, and III, respectively, with median survivals of 26.4, 10.5, and 3.5 months, respectively. The alternate cTnI+NT-proBNP model predicted median survivals of 27.2, 11.1, and 4.1 months, respectively. Conclusion: Stratification of AL patients into three stages is possible with two readily available and reproducible tests setting the stage for more consistent and reliable cross comparisons of therapeutic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
Kyle, R. A., & Ma, G. (1995) · PubMed · Cited by 1,255
Self-citationIt’s Time for a Change to a Troponin Standard
Jaffe, A. S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F. S., Galvani, M., & Katus, H. (2000) · Circulation · doi:10.1161/01.cir.102.11.1216 · Cited by 643
Self-citationJames, S. K., Lindahl, B., Siegbahn, A., Stridsberg, M., Venge, P., Armstrong, P., Barnathan, E. S., Califf, R., Topol, E. J., Simoons, M. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000079170.10579.dc · Cited by 579
Tei, C., Dujardin, K. S., Hodge, D. O., Kyle, R. A., Jamil Tajik, A., & Seward, J. B. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00202-1 · Cited by 496
Self-citationApple, F. S., Wu, A. H. B., & Jaffe, A. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124048 · Cited by 397
Self-citationKlein, A. L., Hatle, L. K., Taliercio, C. P., Oh, J. K., Kyle, R. A., Gertz, M. A., Bailey, K. R., Seward, J. B., & Tajik, A. J. (1991) · Circulation · doi:10.1161/01.cir.83.3.808 · Cited by 356
Self-citationRaymond, I., Groenning, B. A., Hildebrandt, P. R., Nilsson, J. C., Baumann, M., Trawinski, J., & Pedersen, F. (2003) · Heart · doi:10.1136/heart.89.7.745 · Cited by 351
Dispenzieri, A. A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., McConnell, J. P., Litzow, M. R., Gastineau, D. A., Tefferi, A., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0390 · Cited by 320
Self-citationSurvival in patients with primary systemic amyloidosis and raised serum cardiac troponins
Dispenzieri, A., Kyle, R. A., Gertz, M. A., Therneau, T. M., Miller, W. L., Chandrasekaran, K., McConnell, J. P., Burritt, M. F., & Jaffe, A. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13396-x · Cited by 317
Self-citationPrognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
Shipp, M. (1994) · Blood · doi:10.1182/blood.v83.5.1165.1165 · Cited by 278
Cueto-Garcia, L., Reeder, G. S., Kyle, R. A., Wood, D. L., Seward, J. B., Naessens, J., Offord, K. P., Greipp, P. R., Edwards, W. D., & Tajik, A. J. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80475-7 · Cited by 273
Self-citationWu, A. H. B., Smith, A. M., Wieczorek, S. J., Mather, J. F., Duncan, B. H., White, C. M., McGill, C. C., Katten, D. M., & Heller, G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00741-0 · Cited by 260
Ottani, F., Galvani, M., Nicolini, F. A., Ferrini, D., Pozzati, A., Di Pasquale, G., & Jaffe, A. S. (2000) · American Heart Journal · doi:10.1067/mhj.2000.111107 · Cited by 257
Self-citationMerlini, G., Ascari, E., Amboldi, N., Bellotti, V, Arbustini, E., Perfetti, V, Ferrari, M., Zorzoli, I., Marinone, M. G., & Garini, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2959 · Cited by 205
Hammerer-Lercher, A., Neubauer, E., Müller, S., Pachinger, O., Puschendorf, B., & Mair, J. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00578-2 · Cited by 188
Sanchorawala, V, Wright, D., Seldin, D., Dember, L., Finn, K., Falk, R., Berk, J., Quillen, K., & Skinner, M. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703200 · Cited by 168
Stem cell transplantation for the management of primary systemic amyloidosis
Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Gastineau, D. A., Chen, M. G., Ansell, S. M., Inwards, D. J., Micallef, I. N. M., Tefferi, A., & Litzow, M. R. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01208-1 · Cited by 160
Self-citationDispenzieri, A., Lacy, M. Q., Kyle, R. A., Therneau, T. M., Larson, D. R., Rajkumar, S. V., Fonseca, R., Greipp, P. R., Witzig, T. E., Lust, J. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3350 · Cited by 159
Self-citationRight Ventricular Dilation in Primary Amyloidosis
Patel, A. R., Dubrey, S. W., Mendes, L. A., Skinner, M. M., Cupples, L. A., Falk, R. H., & Davidoff, R. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00400-1 · Cited by 114
Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation
Miller, W. L., Wright, R. S., McGregor, C. G. A., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01877-x · Cited by 44
Self-citationPhase II trial of α‐tocopherol (vitamin E) in the treatment of primary systemic amyloidosis
Gertz, M. A., & Kyle, R. A. (1990) · American Journal of Hematology · doi:10.1002/ajh.2830340112 · Cited by 22
Self-citation
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Kumar, S., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Colby, C., Laumann, K., Zeldenrust, S. R., Leung, N., Dingli, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5724 · Cited by 1,137
Self-citationWechalekar, A. D., Gillmore, J. D., & Hawkins, P. N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01274-x · Cited by 994
Palladini, G., Dispenzieri, A., Gertz, M. A., Kumar, S., Wechalekar, A., Hawkins, P. N., Schönland, S., Hegenbart, U., Comenzo, R., Kastritis, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.7614 · Cited by 974
Self-citation
Metadata
- Authors
- Dispenzieri, A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., Greipp, P. R., Witzig, T. E., Lust, J. A., Rajkumar, S. V., Fonseca, R., Zeldenrust, S. R., McGregor, C. G. A., & Jaffe, A. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-09-15
- Volume
- 22
- Issue
- 18
- Pages
- 3751-3757
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2107403553
- Cited by
- 985
- References
- 23
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.